These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2882805)

  • 1. BW A575C, a chemically novel agent with angiotensin converting enzyme inhibitor and beta-adrenoceptor-blocking properties.
    Allan G; Cambridge D; Hardy GW; Follenfant MJ
    Br J Pharmacol; 1987 Mar; 90(3):609-15. PubMed ID: 2882805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
    Cambridge D; Whiting MV; Allan G
    Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BW A575C: pharmacological profile in vivo of a novel angiotensin converting enzyme inhibitor and beta-blocker.
    Cambridge D; Allan G; Hardy GW; Follenfant MJ; Ford A; Oliver PL
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S64-8. PubMed ID: 2454371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.
    Cambridge D; Whiting MV; Butterfield LJ; Allan G
    Br J Pharmacol; 1992 Jun; 106(2):342-7. PubMed ID: 1356560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
    Sybertz EJ; Baum T; Ahn HS; Nelson S; Eynon E; Desiderio DM; Pula K; Becker F; Sabin C; Moran R; Vander Vliet G; Kastner B; Smith E
    J Cardiovasc Pharmacol; 1983; 5(4):643-54. PubMed ID: 6193364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiotensin converting enzyme by (R)-3-[(S)-1-carboxy-5-(4-piperidyl)pentyl]amino-4-oxo-2,3,4,5-tetra- hydro-1,5-benzothiazepine-6-acetic acid (CV-5975), a non-sulfhydryl compound.
    Inada Y; Tanabe M; Itoh K; Sugihara H; Nishikawa K
    Jpn J Pharmacol; 1988 Nov; 48(3):323-30. PubMed ID: 2851678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Rubin B; Powell JR; Petrillo EW; Cushman DW
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):730-6. PubMed ID: 2481187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological properties of FPL 63547, a novel inhibitor of angiotensin-converting enzyme.
    Carr RD; Higgs L; Killingback PG; Nicol AK; O'Connor SE; Robson A; Wells E; Simpson WT
    Br J Pharmacol; 1990 May; 100(1):83-9. PubMed ID: 2164863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
    Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
    Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibitory activity of SCH 33844 (spirapril) in rats, dogs and monkeys.
    Sybertz EJ; Baum T; Ahn HS; Desiderio DM; Pula KK; Tedesco R; Washington P; Sabin C; Smith E; Becker F
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):216-29. PubMed ID: 3036028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the preclinical cardiovascular pharmacology of cilazapril, a new angiotensin converting enzyme inhibitor.
    Waterfall JF
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):139S-150S. PubMed ID: 2527528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.
    Inada Y; Terashita Z; Imura Y; Tanabe M; Nishikawa K; Kikuchi S
    Jpn J Pharmacol; 1986 Sep; 42(1):99-108. PubMed ID: 3025487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the blood pressure of beta-adrenoceptor blocking drugs, particularly in relation to the mechanism of the pressor action induced by beta-adrenoceptor blocking drugs in rats (author's transl)].
    Maekawa H
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):251-61. PubMed ID: 6124489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.